论文部分内容阅读
临床有效的抗病毒,特别是抗疱疹组病毒的新药正在发展。阿糖腺苷能降低某些免疫抑制病人单纯疱疹病毒脑炎、新生儿疱疹和水痘带状疱疹感染的死亡率。无环乌苷对免疫抑制或正常者都能缩短皮肤粘膜单纯疱疹病毒和水痘带状疱疹首次感染或复发的病程。近几个月来有许多干扰素制品及其临床抗病毒应用报导。若干种化合物在体外具有抗疱疹病毒活性的报导也日益增多。一磷酸腺苷(AMP)是细胞代谢和核酸合成的中间产物。Sklar等报导了AMP在带状疱疹的应用。提出肌注AMP能缩短病毒扩散时间、皮损痊愈时间和疼痛的时间,包括治疗后遗神轻痛。但本文作者提醒人们注意,应
New and clinically effective antiviral drugs, especially anti-herpes viruses, are evolving. Vidarabine reduces the mortality of herpes simplex virus encephalitis, herpes zoster and varicella zoster infections in some immunosuppressed patients. Acyclovir on immune suppression or normal can reduce the skin mucosal herpes simplex virus and varicella zoster the first infection or relapse course. There have been many reports of interferon products and their clinical application in recent months. Several compounds have also been reported to have anti-herpesvirus activity in vitro in increasing numbers. Adenosine monophosphate (AMP) is an intermediate product of cellular metabolism and nucleic acid synthesis. Sklar et al. Reported the use of AMP in herpes zoster. It is proposed that intramuscular AMP can shorten the time of virus spreading, the time of healing and the duration of pain, including the mild pain after treatment. But the authors remind people to pay attention